Navigation Links
Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
Date:9/5/2007

hase II clinical trial of EVT 201 in elderly patients with primary insomnia for further differentiation is ongoing. Top-line results from this trial are expected to be announced in October 2007.

Webcast Presentation and Conference Call

Evotec will hold a conference call today at 11.00 am CET (10.00 am UK time/05.00 am EST, 07.00 pm AEST) to present details on positive Phase II study in insomnia with EVT 201. Dr John Kemp, Chief Research & Development Officer, and Dr Tim Tasker, Executive Vice President, Clinical Development will lead the call.

Australia: +61-2-8223-9234

Germany: +49-69-9897-2631

UK: +44-20-7138-0814

Switzerland: +41-44-800-9659

US: +1-718-354-1157

Webcast: http://www.evotec.com

The on-demand version of the webcast will be available on our website: http://www.evotec.com - Investors - Webcasts.

Contact:

Evotec AG

Anne Hennecke

SVP, Investor Relations & Corporate Communications

Phone: +49-(0)40-56081-286

Fax: +49-(0)40-56081-333

E-Mail: anne.hennecke@evotec.com


'/>"/>
SOURCE Evotec AG
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- Ambit Biosciences Corporation announced today the enrollment and ... Cancer Center of the first patient in the ACE ... fficacy) Phase 2 pivotal trial in patients with ... is a novel, orally available, potent and highly selective ... tyrosine kinase-3 (FLT3) inhibitor. The ACE study is ...
(Date:12/11/2009)... December 11, 2009 -- Esco announces the opening of a NEW ... as a technical service, training and logistics center to support Esco,s ... New Product Introductions (NPI) for temperature-controlled laboratory equipment. , ... ... opening of a NEW 2nd North American facility in Marietta, OH. ...
(Date:12/10/2009)... YORK, Dec. 10 With the economy and ... Wall Street,s largest, fastest-growing small cap equity research provider, ... unique investment opportunities within the micro cap market at ... on January 11, 2010 at the Grand Hyatt Hotel ... companies are overlooked and undervalued by much of Wall ...
(Date:12/10/2009)... Vivakor, Inc. (OTC Bulletin Board: VIVK) today ... exclusive, $5 million license agreement with consumer ... ). The agreement exclusively licenses to ... nutraceutical formulation developed by Vivakor and provides ... Vivakor for Regeneca. Under the terms of ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
(Date:12/11/2009)... studying how bacteria under stress collectively weigh and initiate ... into how humans make strategic decisions that affect their ... , Their study, published this week in the early ... National Academy of Sciences , was accomplished when the ... describe the complex interplay of genes and proteins that ...
(Date:12/11/2009)... an associate professor of anthropology at the University of ... Kenya to understand how violence shapes the health of ... of her and her colleagues, research," Documenting the health ... northern Kenya: A conceptual framework," is currently published in ... , in collaboration with the British medical journal the ...
(Date:12/11/2009)... Arno Motulsky, the senior editor of the 4th edition ... Human Genetics, was recently given the Victor A. McKusick ... contributions to the field of human genetics, was presented ... American Society of Human Genetics on 24 October 2009 ... Medicine and Genome Sciences at the University of Washington ...
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2Mapping the Link Between Alcohol Cancer 60159 1Mapping the Link Between Alcohol Cancer 60159 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 1Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 3Dr Lawrence Brown Named President of the Child Neurology Foundation 60155 1Dr Lawrence Brown Named President of the Child Neurology Foundation 60155 2
... WALNUT CREEK, Calif. The U.S. Department of Energy Joint ... assembly of the soybean (Glycine max) genetic code, making ... new breeding strategies for one of the world,s most ... 70 percent of the world,s edible protein, but also ...
... 8, 2008 Animal feeding operations are an important ... carbon dioxideknown greenhouse gases. Recent inventories suggest that ... methane emissions. As a consequence, greenhouse gas emissions ... development and sustainability of animal production and technologies ...
... help clear the plaques in the brain associated with Alzheimer,s ... The plaques are known to lead to the progressive death ... of dementia. , Sodium valproate - which is marketed as ... at the University of Leeds to reactivate the body,s own ...
Other Biology News:DOE Joint Genome Institute completes soybean genome 2DOE Joint Genome Institute completes soybean genome 3Oil spray reduces greenhouse gas emissions from pig finishing barns 2Epilepsy drug shows potential for Alzheimer's treatment 2
Request Info...
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Request Info...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Biology Products: